Alain Gelibter, Paola Malaguti, Serena Di Cosimo, Emilio Bria, Enzo Maria Ruggeri, Paolo Carlini, Fabio Carboni, Giuseppe Maria Ettorre, Mario Pellicciotta, Diana Giannarelli, Edmondo Terzoli, Francesco Cognetti and Michele Milella Fixed dose-rate gemcitabine infusion as first-line treatment for advanced-stage carcinoma of the pancreas and biliary tree Cancer 104
Version of Record online: 2 AUG 2005 | DOI: 10.1002/cncr.21286
Gemcitabine infused at a fixed dose rate (10 mg/m2 per minute) appears to be active and well tolerated in patients with advanced-stage pancreatic and biliary tree carcinoma. The survival and clinical benefit results noted with this regimen were encouraging and prompted further evaluation of this schedule.
Complete the form below and we will send an e-mail message containing a link to the selected article on your behalf
Required = Required Field